Answer:
The statement which indicates that the patient has an accurate understanding of the new medication is; I have read that carbidopa-levodopa is quite short-acting so I will have to take it several times a day.
Explanation:
The half-life of both carbidopa-levodopa medication is approximately 2 hours with duration of action of a dose of 5 hours. This means that patients must take it more than once daily.
In addition, carbidopa-levodopa does not change the course of the Parkinson's disease and prescribed doses are not usually based on the short-term severity of symptoms. Hence, the patient's medications history must be evaluated.
C. Increases digestibility
